XML 26 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue Recognition
6 Months Ended
Jul. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Disaggregation of Revenue
The following table summarizes revenue by region based on the billing address of customers:
Three Months Ended July 31, Six Months Ended July 31,
2022202120222021
AmountPercentage of
Revenue
AmountPercentage of
Revenue
AmountPercentage of
Revenue
AmountPercentage of
Revenue
(in thousands, except percentages)
Americas$762,690 69 %$681,414 67 %$1,491,071 69 %$1,317,199 67 %
Asia Pacific (“APAC”)
149,355 14 135,321 13 298,175 14 259,084 13 
Europe, Middle East, and Africa (“EMEA”)
187,413 17 204,760 20 384,012 17 401,449 20 
Total$1,099,458 100 %$1,021,495 100 %$2,173,258 100 %$1,977,732 100 %
Contract Balances
We receive payments from customers based on a billing schedule as established in our customer contracts. Accounts receivable are recorded when we contractually have the right to consideration. In some arrangements, a right to consideration for our performance under the customer contract may occur before invoicing to the customer, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net of allowances on the condensed consolidated balance sheets was $70.6 million and $59.7 million as of July 31, 2022 and January 31, 2022, respectively.
Contract liabilities consist of deferred revenue. Revenue is deferred when we have the right to invoice in advance of performance under a customer contract. The current portion of deferred revenue balances is recognized over the next 12 months. The amount of revenue recognized during the three months ended July 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $572.7 million and $480.5 million, respectively, and $867.6 million and $660.1 million during the six months ended July 31, 2022 and 2021, respectively.
Remaining Performance Obligations
The terms of our subscription agreements are monthly, annual, and multiyear, and we may bill for the full term in advance or on an annual, quarterly, or monthly basis, depending on the billing terms with customers. As of July 31, 2022, the aggregate amount of the transaction price allocated to our remaining performance obligations was $3,213.0 million, which consists of both billed consideration in the amount of $1,401.1 million and unbilled consideration in the amount of $1,811.9 million that we expect to recognize as revenue. We expect to recognize 61% of our remaining performance obligations as revenue over the next 12 months and the remainder thereafter.